Compare Sun Pharma with Aurobindo Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUN PHARMA vs AUROBINDO PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUN PHARMA AUROBINDO PHARMA SUN PHARMA/
AUROBINDO PHARMA
 
P/E (TTM) x 31.9 7.7 414.7% View Chart
P/BV x 4.2 1.9 222.9% View Chart
Dividend Yield % 0.9 0.6 162.6%  

Financials

 SUN PHARMA   AUROBINDO PHARMA
EQUITY SHARE DATA
    SUN PHARMA
Mar-21
AUROBINDO PHARMA
Mar-21
SUN PHARMA/
AUROBINDO PHARMA
5-Yr Chart
Click to enlarge
High Rs6541,023 63.9%   
Low Rs339333 101.6%   
Sales per share (Unadj.) Rs139.6422.8 33.0%  
Earnings per share (Unadj.) Rs9.592.0 10.4%  
Cash flow per share (Unadj.) Rs18.2110.0 16.5%  
Dividends per share (Unadj.) Rs7.504.00 187.5%  
Avg Dividend yield %1.50.6 256.3%  
Book value per share (Unadj.) Rs193.6374.3 51.7%  
Shares outstanding (eoy) m2,399.34585.94 409.5%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x3.61.6 221.5%   
Avg P/E ratio x52.17.4 706.6%  
P/CF ratio (eoy) x27.36.2 442.3%  
Price / Book Value ratio x2.61.8 141.4%  
Dividend payout %78.84.3 1,811.1%   
Avg Mkt Cap Rs m1,190,430397,398 299.6%   
No. of employees `000NANA-   
Total wages/salary Rs m68,62235,350 194.1%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m334,981247,746 135.2%  
Other income Rs m8,5923,809 225.6%   
Total revenues Rs m343,573251,555 136.6%   
Gross profit Rs m41,61681,480 51.1%  
Depreciation Rs m20,80010,554 197.1%   
Interest Rs m1,414745 189.9%   
Profit before tax Rs m27,99473,990 37.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,14720,098 25.6%   
Profit after tax Rs m22,84753,892 42.4%  
Gross profit margin %12.432.9 37.8%  
Effective tax rate %18.427.2 67.7%   
Net profit margin %6.821.8 31.4%  
BALANCE SHEET DATA
Current assets Rs m304,421198,235 153.6%   
Current liabilities Rs m161,456106,652 151.4%   
Net working cap to sales %42.737.0 115.5%  
Current ratio x1.91.9 101.4%  
Inventory Days Days14919 776.7%  
Debtors Days Days9952 191.3%  
Net fixed assets Rs m336,682135,778 248.0%   
Share capital Rs m2,399586 409.5%   
"Free" reserves Rs m462,229218,713 211.3%   
Net worth Rs m464,628219,299 211.9%   
Long term debt Rs m8,9811,684 533.3%   
Total assets Rs m641,103334,013 191.9%  
Interest coverage x20.8100.3 20.7%   
Debt to equity ratio x00 251.7%  
Sales to assets ratio x0.50.7 70.4%   
Return on assets %3.816.4 23.1%  
Return on equity %4.924.6 20.0%  
Return on capital %6.233.8 18.4%  
Exports to sales %053.8 0.0%   
Imports to sales %016.4 0.0%   
Exports (fob) Rs mNA133,248 0.0%   
Imports (cif) Rs mNA40,615 0.0%   
Fx inflow Rs m84,493133,248 63.4%   
Fx outflow Rs m30,33444,946 67.5%   
Net fx Rs m54,15988,302 61.3%   
CASH FLOW
From Operations Rs m61,70433,289 185.4%  
From Investments Rs m5,3625,987 89.6%  
From Financial Activity Rs m-59,805-13,648 438.2%  
Net Cashflow Rs m5,96425,831 23.1%  

Share Holding

Indian Promoters % 54.5 48.8 111.7%  
Foreign collaborators % 0.0 3.1 -  
Indian inst/Mut Fund % 33.8 37.2 90.8%  
FIIs % 12.1 21.7 55.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 45.5 48.2 94.5%  
Shareholders   675,908 329,940 204.9%  
Pledged promoter(s) holding % 6.5 24.4 26.7%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUN PHARMA With:   DISHMAN PHARMA  BROOKS LAB  WINDLAS BIOTECH  GLENMARK PHARMA  BLISS GVS PHARMA  



Today's Market

Sensex Ends 383 Points Higher; Metal and Realty Stocks Rally(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended higher.

Related Views on News

SUN PHARMA 2020-21 Annual Report Analysis (Annual Result Update)

Oct 22, 2021 | Updated on Oct 22, 2021

Here's an analysis of the annual report of SUN PHARMA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

AUROBINDO PHARMA Announces Quarterly Results (1QFY22); Net Profit Down 2.0% (Quarterly Result Update)

Aug 16, 2021 | Updated on Aug 16, 2021

For the quarter ended June 2021, AUROBINDO PHARMA has posted a net profit of Rs 8 bn (down 2.0% YoY). Sales on the other hand came in at Rs 57 bn (down 3.8% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

AUROBINDO PHARMA 2020-21 Annual Report Analysis (Annual Result Update)

Aug 9, 2021 | Updated on Aug 9, 2021

Here's an analysis of the annual report of AUROBINDO PHARMA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of AUROBINDO PHARMA. Also includes updates on the valuation of AUROBINDO PHARMA.

SUN PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 87.4% (Quarterly Result Update)

Feb 1, 2021 | Updated on Feb 1, 2021

For the quarter ended December 2020, SUN PHARMA has posted a net profit of Rs 19 bn (up 87.4% YoY). Sales on the other hand came in at Rs 88 bn (up 8.4% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA 2019-20 Annual Report Analysis (Annual Result Update)

Dec 11, 2020 | Updated on Dec 11, 2020

Here's an analysis of the annual report of SUN PHARMA for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

More Views on News

Most Popular

5 Green Energy Stocks to Watch as India Readies for a Revolution(Views On News)

Oct 13, 2021

The excitement around green energy stocks has opened up a huge contrarian opportunity in the traditional energy space.

Could HDFC Bank be a Big EV Winner? The Answer Will Surprise You...(Profit Hunter)

Oct 13, 2021

Why should investors take it for granted that India's Tesla will be one of the major auto stocks?

Tata Group Stocks are on Fire: Which one Should You Buy?(Profit Hunter)

Oct 15, 2021

Tata group stocks are on fire. Find out which one deserves your attention.

Massive Surge in the Shares of Tata Motors Today. Key Factors Favouring the Rally(Views On News)

Oct 13, 2021

Tata Motors zooms 23% after report of TPG investing Rs 75 bn in EV arm.

India's Big PSU Selloff: Watch Out for these Top Stocks(Views On News)

Oct 15, 2021

The government's plan to divest its stakes in PSUs could spark off a rally in these four stocks.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SUN PHARMA SHARE PRICE


Oct 26, 2021 03:37 PM

TRACK SUN PHARMA

  • Track your investment in SUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE SUN PHARMA WITH

MARKET STATS